REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial | |
Anonymous Coward User ID: 78938172 United States 09/06/2021 09:49 PM Report Abusive Post Report Copyright Violation | |
Butch DeFeo User ID: 80788608 United States 09/06/2021 09:57 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial You can't trust any government medical studies related to this fake COVID pandemic. :DOCSRBAFFLED::redblueLED::DONTBEAPANDEMICS: Only you can stop the fake pandemic for yourself, no one will ever tell you the pandemic is over. It's time to WIN. |
Anonymous Coward User ID: 79214506 United States 09/06/2021 09:59 PM Report Abusive Post Report Copyright Violation | |
pish Turtle Hermit User ID: 78227579 United States 09/06/2021 10:03 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial You can't trust any government medical studies related to this fake COVID pandemic. Quoting: Butch DeFeo Better to trust a YouTube or Bitchute video eh? Always remember these words: Work hard, study well, and eat and sleep plenty! That is the Turtle Hermit way! We must master the art of peace in addition to the art of war! |
Anonymous Coward User ID: 79518852 United States 09/06/2021 10:25 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial I trust the Japanese government more than the USA's at this point. Quoting: Anonymous Coward 79214506 This clinical trial was not performed in the USA and it would be really difficult to fake a clinical trial with 500 patients and dozens of doctors. So did Japan report a randomised clinical trial? Got a link? |
Anonymous Coward User ID: 79518852 United States 09/06/2021 10:28 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Here's an earlier RCT, reported in January Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial Key Points Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo (median time to resolution of symptoms, 10 vs 12 days; hazard ratio for resolution of symptoms, 1.07). Meaning The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand effects on other clinically relevant outcomes. [link to jamanetwork.com (secure)] |
Cap’n Obvious User ID: 78963999 United States 09/06/2021 10:32 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives“ I have never seen this type of subjective, emotionally laden, wording in a study summary…. And I have read a thousand of them. But, this is a weak observational, unscientific approach, to doing research and doesn’t mean anything anyway. Have a nice day = GFY. GFY = Go Fuck Yourself. If this offends you then have a nice day. |
Anonymous Coward User ID: 79518852 United States 09/06/2021 10:32 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India Background: There has been a growing interest in ivermectin ever since it was reported to have an in-vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This trial was conducted to test the efficacy of ivermectin in mild and moderate coronavirus disease 19 (COVID-19). Methods: A double blind, parallel, randomised, placebo-controlled trial conducted among adult COVID-19 patients with mild to moderate disease severity on admission in a COVID dedicated tertiary healthcare of eastern India. Enrolment was done between 1st August and 31st October 2020. On day 1 and 2 post enrolment, patients in the intervention arm received ivermectin 12 mg while the patients in the non-interventional arm received placebo tablets. Conclusions: Inclusion of ivermectin in treatment regimen of mild to moderate COVID-19 patients could not be said with certainty based on our study results as it had shown only marginal benefit in successful discharge from the hospital with no other observed benefits. [link to www.researchgate.net (secure)] |
Traveling User ID: 80225469 United States 09/06/2021 10:35 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Ivermectin was given for only 2 days and the dose is not revealed in this abstract. Cant make any definitive conclusions with this study compared to patients given higher dose and for more days which is what FLCCC recommends. Last Edited by Traveling on 09/06/2021 10:35 PM |
Anonymous Coward User ID: 79518852 United States 09/06/2021 10:35 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives“ Quoting: Cap’n Obvious I have never seen this type of subjective, emotionally laden, wording in a study summary…. And I have read a thousand of them. But, this is a weak observational, unscientific approach, to doing research and doesn’t mean anything anyway. I think most of us would agree that the world is a different place as a result of SARS-CoV-2. But this was a scientific approach, being a relatively large placebo controlled randomized clinical trial with a peer reviewed publication. Seems you are reaching hard to discredit it in order to support your own anecdotal narrative by criticising the wording of the introduction. |
Cap’n Obvious User ID: 78963999 United States 09/06/2021 10:44 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Here's an earlier RCT, reported in January Quoting: Anonymous Coward 79518852 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial Key Points Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo (median time to resolution of symptoms, 10 vs 12 days; hazard ratio for resolution of symptoms, 1.07). Meaning The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand effects on other clinically relevant outcomes. [link to jamanetwork.com (secure)] Dose of ivermectin is on low end…. About half what many protocols call for and no zinc. No zinc.. no good, and they knew this beforehand which makes me suspicious. No Doxy or other antibiotic either. Have a nice day = GFY. GFY = Go Fuck Yourself. If this offends you then have a nice day. |
Anonymous Coward User ID: 79518852 United States 09/06/2021 10:45 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Here's an earlier RCT, reported in January Quoting: Anonymous Coward 79518852 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial Key Points Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo (median time to resolution of symptoms, 10 vs 12 days; hazard ratio for resolution of symptoms, 1.07). Meaning The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand effects on other clinically relevant outcomes. [link to jamanetwork.com (secure)] Dose of ivermectin is on low end…. About half what many protocols call for and no zinc. No zinc.. no good, and they knew this beforehand which makes me suspicious. No Doxy or other antibiotic either. So where did you get your medical degree? Bitchute? |
Anonymous Coward User ID: 79518852 United States 09/06/2021 10:46 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Here's an earlier RCT, reported in January Quoting: Anonymous Coward 79518852 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial Key Points Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo (median time to resolution of symptoms, 10 vs 12 days; hazard ratio for resolution of symptoms, 1.07). Meaning The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand effects on other clinically relevant outcomes. [link to jamanetwork.com (secure)] Dose of ivermectin is on low end…. About half what many protocols call for and no zinc. No zinc.. no good, and they knew this beforehand which makes me suspicious. No Doxy or other antibiotic either. So where did you get your medical degree? Bitchute? [imgur] [link to imgur.com (secure)] |
Anonymous Coward User ID: 78455313 United States 09/06/2021 10:48 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. Quoting: Anonymous Coward 78152458 Objective: To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. Design, setting and participants: A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 positive nasal swabs were contacted within 48 h by telephone to invite them to participate. The trial randomized 501 patients between August 19th 2020 and February 22nd 2021. Conclusion: Ivermectin had no significant effect on preventing hospitalization of patients with COVID-19. Patients who received ivermectin required invasive MVS earlier in their treatment. No significant differences were observed in any of the other secondary outcomes. [link to pubmed.ncbi.nlm.nih.gov (secure)] They also said the virus wasn’t enhanced but the financed enhancement of the virus in wuhan. They have zero credibility. |
Anonymous Coward User ID: 77181591 United States 09/06/2021 10:48 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial I'd trust a Nork "randomized, double-blind, placebo-controlled" study rather than one by the US government. The US has proven it's out to kill its own citizens. |
Cap’n Obvious User ID: 78963999 United States 09/06/2021 10:48 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives“ Quoting: Cap’n Obvious I have never seen this type of subjective, emotionally laden, wording in a study summary…. And I have read a thousand of them. But, this is a weak observational, unscientific approach, to doing research and doesn’t mean anything anyway. I think most of us would agree that the world is a different place as a result of SARS-CoV-2. But this was a scientific approach, being a relatively large placebo controlled randomized clinical trial with a peer reviewed publication. Seems you are reaching hard to discredit it in order to support your own anecdotal narrative by criticising the wording of the introduction. I didn’t try hard at all…. The summary lost me right up front and i didn’t bother to get into details. I once beard this guy I worked with say that studies should express “Facts. Bland facts.“ That was Fauci.. circa 1990. Have a nice day = GFY. GFY = Go Fuck Yourself. If this offends you then have a nice day. |
Anonymous Coward User ID: 78455313 United States 09/06/2021 10:50 PM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 80666123 United States 09/06/2021 10:51 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Ivermectin was given for only 2 days and the dose is not revealed in this abstract. Cant make any definitive conclusions with this study compared to patients given higher dose and for more days which is what FLCCC recommends. Quoting: Traveling Below are the dosages from the study: “ Those weighing up to 80 Kg received 2 tablets of 6 mg (mg) each at inclusion and another 2 tablets of 6 mg each 24 h after the first dose (total 24 mg). Those weighing more than 80 kg and up to 110 kg received 3 tablets of 6 mg each at inclusion and another 3 tablets of 6 mg each 24 h after the first dose (total 36 mg). Those weighing more than 110 kg received 4 tablets of 6 mg each at inclusion and another 4 tablets of 6 mg each 24 h after the first dose (total 48 mg).” I’m not sure if that is anywhere close to the dose FLCCC recommends though. |
Anonymous Coward User ID: 79518852 United States 09/06/2021 10:53 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives“ Quoting: Cap’n Obvious I have never seen this type of subjective, emotionally laden, wording in a study summary…. And I have read a thousand of them. But, this is a weak observational, unscientific approach, to doing research and doesn’t mean anything anyway. I think most of us would agree that the world is a different place as a result of SARS-CoV-2. But this was a scientific approach, being a relatively large placebo controlled randomized clinical trial with a peer reviewed publication. Seems you are reaching hard to discredit it in order to support your own anecdotal narrative by criticising the wording of the introduction. I didn’t try hard at all…. The summary lost me right up front and i didn’t bother to get into details. I once beard this guy I worked with say that studies should express “Facts. Bland facts.“ That was Fauci.. circa 1990. So how do you discredit the data of this peer reviewed publication? Based on your superior insight as a scholar of epidemiology, I am sure the editorial board would welcome your criticism o the introduction and consider withdrawing the entire report based on that. Besides, I don't know about you, but COVID has definitely changed my live as it has for my family and everyone I know. I don't disagree with that statement. |
Anonymous Coward User ID: 78700202 United States 09/06/2021 10:55 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Ivermectin was given for only 2 days and the dose is not revealed in this abstract. Cant make any definitive conclusions with this study compared to patients given higher dose and for more days which is what FLCCC recommends. Quoting: Traveling Below are the dosages from the study: “ Those weighing up to 80 Kg received 2 tablets of 6 mg (mg) each at inclusion and another 2 tablets of 6 mg each 24 h after the first dose (total 24 mg). Those weighing more than 80 kg and up to 110 kg received 3 tablets of 6 mg each at inclusion and another 3 tablets of 6 mg each 24 h after the first dose (total 36 mg). Those weighing more than 110 kg received 4 tablets of 6 mg each at inclusion and another 4 tablets of 6 mg each 24 h after the first dose (total 48 mg).” I’m not sure if that is anywhere close to the dose FLCCC recommends though. So where did FLCCC come up with their recommended dosage? Have they conducted trials? |
Cap’n Obvious User ID: 78963999 United States 09/06/2021 10:55 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Here's an earlier RCT, reported in January Quoting: Anonymous Coward 79518852 Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial Key Points Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo (median time to resolution of symptoms, 10 vs 12 days; hazard ratio for resolution of symptoms, 1.07). Meaning The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand effects on other clinically relevant outcomes. [link to jamanetwork.com (secure)] Dose of ivermectin is on low end…. About half what many protocols call for and no zinc. No zinc.. no good, and they knew this beforehand which makes me suspicious. No Doxy or other antibiotic either. So where did you get your medical degree? Bitchute? Friend…. I worked in the infectious disease field for decades before moving into management. That time included many years working directly for Fauci at NIH. Per his recommendations, I also worked at the CDC, Mayo in Rochester, Emory university; Duke…. And spent many years working in DNA manufacturing.. along with competing many other research projects at other major universities. I have been around. There are 10,000s of thousands or studies…. If the summary does not pass muster, I move on. This one didn’t pass. Have a nice day = GFY. GFY = Go Fuck Yourself. If this offends you then have a nice day. |
sunwatcher User ID: 80829689 Brazil 09/06/2021 11:11 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. Quoting: Anonymous Coward 78152458 Objective: To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. Design, setting and participants: A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 positive nasal swabs were contacted within 48 h by telephone to invite them to participate. The trial randomized 501 patients between August 19th 2020 and February 22nd 2021. Conclusion: Ivermectin had no significant effect on preventing hospitalization of patients with COVID-19. Patients who received ivermectin required invasive MVS earlier in their treatment. No significant differences were observed in any of the other secondary outcomes. [link to pubmed.ncbi.nlm.nih.gov (secure)] Hospitalization: "14 (5.60%) belonged to the ivermectin group and 21 (8.37%) to the placebo group. There were no statistically significant differences between the two groups" this is How BIASED "studies" to discredit something are done "scientifically": 33% MORE in PLACEBO group than the other NOW is NOT "statistically significant"...! I'm becoming an expert in identifying bikes'n'boats thanks to GLP |
Traveling User ID: 80225469 United States 09/06/2021 11:14 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Ivermectin was given for only 2 days and the dose is not revealed in this abstract. Cant make any definitive conclusions with this study compared to patients given higher dose and for more days which is what FLCCC recommends. Quoting: Traveling Below are the dosages from the study: “ Those weighing up to 80 Kg received 2 tablets of 6 mg (mg) each at inclusion and another 2 tablets of 6 mg each 24 h after the first dose (total 24 mg). Those weighing more than 80 kg and up to 110 kg received 3 tablets of 6 mg each at inclusion and another 3 tablets of 6 mg each 24 h after the first dose (total 36 mg). Those weighing more than 110 kg received 4 tablets of 6 mg each at inclusion and another 4 tablets of 6 mg each 24 h after the first dose (total 48 mg).” I’m not sure if that is anywhere close to the dose FLCCC recommends though. These are much lower total doses Also the study doesn’t indicate what other treatments the patients were getting. This study has major limitations. Last Edited by Traveling on 09/06/2021 11:16 PM |
~LSDMTHC~ User ID: 80745252 United States 09/06/2021 11:21 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial The odds that 5 people in my family including myself were cured of Covid in a matter of days after using ivermectin and it not having been the ivermectin are fucking slim. Floridian. Christian, Father, Hard worker and a millenial. Fuck Big Pharma! Don’t be a pussy, if you leave red at least leave your name. I can’t guarantee I’ll be alive come this time next year… |
Anonymous Coward User ID: 80810855 United States 09/06/2021 11:24 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. Quoting: Anonymous Coward 78152458 Objective: To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. Design, setting and participants: A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 positive nasal swabs were contacted within 48 h by telephone to invite them to participate. The trial randomized 501 patients between August 19th 2020 and February 22nd 2021. Conclusion: Ivermectin had no significant effect on preventing hospitalization of patients with COVID-19. Patients who received ivermectin required invasive MVS earlier in their treatment. No significant differences were observed in any of the other secondary outcomes. [link to pubmed.ncbi.nlm.nih.gov (secure)] There are many studies that prove this is a lying cunt report.... ivermectin works 100% ....... and the more you douchebags keep trying to cut it down, the more obvious it is that it works really good........ damn...... these cunts are so bad at spreading disinfo..... calling everyone a trumpist cultist extremist......lol |
Traveling User ID: 80225469 United States 09/06/2021 11:27 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Using the higher end dose from FLCCC for delta variant in an 80kg person, the dose is 48 mg per day. Total possible dose for 5 days is 240 mg This study did 12 mg for 2 days each, total of 24 mg. Ten times less total dosing. Last Edited by Traveling on 09/06/2021 11:28 PM |
Anonymous Coward User ID: 80207364 United States 09/06/2021 11:27 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives. The scientific community has been investigating re-purposed treatments to prevent disease progression in coronavirus disease (COVID-19) patients. Quoting: Anonymous Coward 78152458 Objective: To determine whether ivermectin treatment can prevent hospitalization in individuals with early COVID-19. Design, setting and participants: A randomized, double-blind, placebo-controlled study was conducted in non-hospitalized individuals with COVID-19 in Corrientes, Argentina. Patients with SARS-CoV-2 positive nasal swabs were contacted within 48 h by telephone to invite them to participate. The trial randomized 501 patients between August 19th 2020 and February 22nd 2021. Conclusion: Ivermectin had no significant effect on preventing hospitalization of patients with COVID-19. Patients who received ivermectin required invasive MVS earlier in their treatment. No significant differences were observed in any of the other secondary outcomes. [link to pubmed.ncbi.nlm.nih.gov (secure)] Say what? Limitations: Low percentage of hospitalization events, dose of ivermectin and not including only high-risk population. |
Anonymous Coward User ID: 68171808 United States 09/06/2021 11:37 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial Why not look at the 31 random controlled trials that found ivermectin 64% effective at improving status. [link to ivmmeta.com (secure)] |
Anonymous Coward User ID: 68171808 United States 09/06/2021 11:38 PM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 68140430 Canada 09/06/2021 11:45 PM Report Abusive Post Report Copyright Violation | Re: REPORT: Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed our lives“ Quoting: Cap’n Obvious I have never seen this type of subjective, emotionally laden, wording in a study summary…. And I have read a thousand of them. But, this is a weak observational, unscientific approach, to doing research and doesn’t mean anything anyway. This^ |